Intelligence » Multiple Sclerosis » Last Week

Subscribe to get latest posts via email or subscribe to a RSS feed.

Tuesday, January 16, 2018 -- NewsRoche’s Ocrevus (ocrelizumab) approved in the European Union for relapsing forms of multiple sclerosis and primary progressive multiple sclerosis.Contributed Author: Roche Holding AG

Monday, January 15, 2018 -- PET imaging may improve diagnosis and monitoring for MS patients...

Thursday, January 11, 2018 -- BACKGROUND AND PURPOSE: Arterial and neck vessel system characteristics of patients with multiple sclerosis have not been previously investigated. Therefore, the aim of this study was to examine the frequency of neck vessels and their cross-sectional areas (in square millimeters) between patients with MS and healthy controls. MATERIALS AND METHODS: In this study, 193 patients with MS and 193 age- and sex-matched healthy controls underwent 2D TOF venography at 3T. The main arterial (carotid and vertebral), venous (internal jugular), and secondary neck vessels were examined at 4 separate cervical levels (C2/3, C4, C5/6, and C7/T1). The ANCOVA adjusted for age, body mass index, smoking status, hypertension, and heart disease was used to compare the differences between patients with MS

Thursday, January 11, 2018 -- BACKGROUND AND PURPOSE: The spatial correlation between WM and cortical GM disease in multiple sclerosis is controversial and has not been previously assessed with perfusion MR imaging. We sought to determine the nature of association between lobar WM, cortical GM, volume and perfusion. MATERIALS AND METHODS: Nineteen individuals with secondary-progressive multiple sclerosis, 19 with relapsing-remitting multiple sclerosis, and 19 age-matched healthy controls were recruited. Quantitative MR perfusion imaging was used to derive CBF, CBV, and MTT within cortical GM, WM, and T2-hyperintense lesions. A 2-step multivariate linear regression (corrected for age, disease duration, and Expanded Disability Status Scale) was used to assess correlations between perfusion and volume measures in global and lobar normal-appearing WM, cortical GM, and T2-hyperintense lesions.

Saturday, January 13, 2018 -- Interview with: Fredrik Piehl MD PhD, prof. of Neurology Neuroimmunology Unit. Dept Clinical Neuroscience Neurology Dept. Karolinska University Hospital (Solna) Stockholm What is the background for this study? What are the main findings? Response: In recent years we have … Continue reading →

Related pages

actrapidflucidetwinrix injectioncerebrolysin dosagemultirich tabletparasoft pricingveritazsinucon ingredientsmebendazole side effectszyrtec odseptran tabletsdemazinoptrex chloramphenicolluminal drugalbuterol precautionshomatropine 5 eye dropsurocholinenew life colostrumotrivin nasal spray dosagezingiber officinale side effectsasert dcetirizine dihydrochloride tabletmegamox 1g side effectsside effect of typhoid feversyrup for constipation in adultsakt 4 treatmentcholecalciferol granules 60000 iu dosagecataplex acp benefitscepacol cough syruprytmonorm tabletthyrolar 3montral medicineepitopoasthalin inhaler wikiextraderm plus exfoliant 1histop medicineduac ingredientseicosapentaenoic acid docosahexaenoic acidetova tabletendometril tabletdiclofenac pot side effectsairtal tabletavil syrupanusol hc ingredientsopexa gel side effectsskinoren cream useslactulose reviewsd norpseudoephedrine hclano ang masamang epekto ng serctriclosan kannada meaningrelaxinem2 tone syrup uses in hindioosure tablet side effectswhat is alum in telugumalanil tabletspanado ingredientsiodide tincturexanthinoldarya variasquill liquid extracttelsartan activuricare side effectscolipaxdemovate creamilvicodynapar medicinemama protinex priceeptoin 300 er side effectswhite petrolatum mineral oillexam druglucas paw paw pricecilest birth controlborage seed oil benefitswhat is anhydrous dextrose